America's growing reliance on weight-loss medications is reshaping the food industry, creating an unexpected boom for condiment and spice manufacturers as consumers seek more flavor in their meals.

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have ...

The two companies had a similar agreement last year, but Novo abruptly canceled it after Hims refused to stop marketing and selling similar drugs. Hims shares rose 47%, while those of New are up ...

Many celebrities continue taking GLP-1s. The results, for better or worse, are undeniably transformative. On the latter end ...

The biggest new restaurant trend is small. Special menus with petite, less expensive portions are popping up all over, from large chains like Olive Garden and The Cheesecake Factory to trendy urban ...

A dramatic rally saw shares of telehealth company Hims & Hers Health, Inc. soar approximately 57% over the course of a single week, closing at $24.77 on Fri ...

Dr Vatsya cautions that using antibiotics for sore throats can harm gut health and lead to antibiotic resistance, emphasising most resolve naturally.

Ten stocks boasted strong gains on Wednesday amid a lackluster wider market, thanks to a flurry of corporate developments including partnerships, product launches, and analyst upgrades, among others.

Walk into almost any dinner party or gathering and mention Ozempic or other GLP-1s. The reaction is nearly always the same: ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...

Ozempic is intended to help people with diabetes manage blood sugar. A dietitian breaks down exactly what Ozempic is, and if ...